Chijimatsu Ryota, Ikeya Makoto, Yasui Yukihiko, Ikeda Yasutoshi, Ebina Kosuke, Moriguchi Yu, Shimomura Kazunori, Hart David A, Hideki Yoshikawa, Norimasa Nakamura
Graduate School of Medicine, Orthopaedic Surgery, Osaka University, Suita, Osaka, Japan.
Graduate School of Frontier Bio Science, Orthopaedic Surgery, Osaka University, Suita, Osaka, Japan.
Stem Cells Int. 2017;2017:1960965. doi: 10.1155/2017/1960965. Epub 2017 May 10.
Mesenchymal stem cells (MSCs) derived from induced pluripotent stem cells (iPSCs) are a promising cell source for the repair of skeletal disorders. Recently, neural crest cells (NCCs) were reported to be effective for inducing mesenchymal progenitors, which have potential to differentiate into osteochondral lineages. Our aim was to investigate the feasibility of MSC-like cells originated from iPSCs via NCCs for osteochondral repair. Initially, MSC-like cells derived from iPSC-NCCs (iNCCs) were generated and characterized in vitro. These iNCC-derived MSC-like cells (iNCMSCs) exhibited a homogenous population and potential for osteochondral differentiation. No upregulation of pluripotent markers was detected during culture. Second, we implanted iNCMSC-derived tissue-engineered constructs into rat osteochondral defects without any preinduction for specific differentiation lineages. The implanted cells remained alive at the implanted site, whereas they failed to repair the defects, with only scarce development of osteochondral tissue in vivo. With regard to tumorigenesis, the implanted cells gradually disappeared and no malignant cells were detected throughout the 2-month follow-up. While this study did not show that iNCMSCs have efficacy for repair of osteochondral defects when implanted under undifferentiated conditions, iNCMSCs exhibited good chondrogenic potential in vitro under appropriate conditions. With further optimization, iNCMSCs may be a new source for tissue engineering of cartilage.
源自诱导多能干细胞(iPSC)的间充质干细胞(MSC)是修复骨骼疾病的一种有前景的细胞来源。最近,有报道称神经嵴细胞(NCC)在诱导间充质祖细胞方面有效,这些祖细胞具有分化为骨软骨谱系的潜力。我们的目的是研究经由NCC源自iPSC的类MSC细胞用于骨软骨修复的可行性。首先,在体外生成并鉴定了源自iPSC-NCC(iNCC)的类MSC细胞。这些源自iNCC的类MSC细胞(iNCMSC)表现出均一的细胞群以及骨软骨分化潜力。在培养过程中未检测到多能性标志物的上调。其次,我们将源自iNCMSC的组织工程构建体植入大鼠骨软骨缺损处,未对特定分化谱系进行任何预诱导。植入的细胞在植入部位存活,但未能修复缺损,在体内仅形成了少量的骨软骨组织。关于肿瘤发生,植入的细胞逐渐消失,在整个2个月的随访中未检测到恶性细胞。虽然这项研究并未表明iNCMSC在未分化条件下植入时对骨软骨缺损修复有效,但iNCMSC在适当条件下在体外表现出良好的软骨形成潜力。通过进一步优化,iNCMSC可能成为软骨组织工程的新来源。